Table 1. Cohort Distribution of Race and Ethnicity, Sex, Age, and Tumor Type.
| Characteristic | No. (%) | ||
|---|---|---|---|
| Overall (N = 34 642) | Lacking guidelines (n = 14 038) | Guidelines available (n = 20 604) | |
| Sex | |||
| Female | 18 888 (54.5) | 6081 (43.3) | 12 807 (62) |
| Male | 15 678 (45.3) | 7934 (56.5) | 7744 (37.6) |
| Unknown | 76 (0.2) | 23 (0.2) | 53 (0.3) |
| Racea | |||
| American Indian or Alaska Native | 84 (0.2) | 23 (0.2) | 61 (0.3) |
| Asian | 816 (2.4) | 335 (2.4) | 481 (2.3) |
| Black or African American | 2664 (7.7) | 924 (6.6) | 1740 (8.4) |
| Native Hawaiian or other Pacific Islander | 25 (<0.1) | 9 (<0.1) | 16 (<0.1) |
| White | 17 422 (50.3) | 7488 (53.3) | 9934 (48.2) |
| Other | 774 (2.2) | 279 (2.0) | 495 (2.4) |
| Unknown | 12 857 (37.1) | 4980 (35.5) | 7877 (38.2) |
| Ethnicity | |||
| Hispanic or Latino | 1546 (4.5) | 485 (3.5) | 1061 (5.1) |
| Not Hispanic or Latino | 9360 (27.0) | 4196 (29.9) | 5164 (25.1) |
| Unknown | 23 736 (68.5) | 9357 (66.7) | 14 379 (69.8) |
| Age at diagnosis, y | |||
| <50 | 4376 (12.6) | 1551 (11.0) | 2825 (14.2) |
| ≥50 | 23 122 (66.7) | 10 274 (73.2) | 12 848 (62.4) |
| Unknown | 7144 (20.6) | 2213 (15.8) | 4931 (23.9) |
| Tumor type | |||
| Breast | 4581 (13.2) | NA | 4581 (22.2) |
| Colorectal | 5303 (15.3) | NA | 5303 (25.7) |
| Endometrial | 1542 (4.5) | NA | 1542 (7.5) |
| Ovarian | 2756 (8.0) | NA | 2756 (13.4) |
| Pancreas | 3535 (10.2) | NA | 3535 (17.2) |
| Prostate | 2887 (8.3) | NA | 2887 (14.0) |
| Esophagus | 747 (2.2) | 747 (5.3) | NA |
| Head and Neck | 1218 (3.5) | 1218 (8.7) | NA |
| Lung | 7668 (22.1) | 7668 (54.6) | NA |
| Bladder | 1188 (3.4) | 1188 (8.5) | NA |
| Brain | 2377 (6.9) | 2377 (16.9) | NA |
| Cholangiocarcinoma | 840 (2.4) | 840 (6.0) | NA |
| P/LP germline variant | 2534 (7.3) | 759 (5.4) | 1775 (8.6) |
Abbreviations: NA, not applicable; P/LP, pathogenic/likely pathogenic.
a
Race and ethnicity are a free response text box that is further categorized during data abstraction of requisition forms.